Christopher McNulty
2016
In 2016, Christopher McNulty earned a total compensation of $566.5K as Chief Financial Officer at InVivo Therapeutics Holdings, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $54,000 |
|---|---|
| Option Awards | $207,902 |
| Salary | $289,322 |
| Other | $15,307 |
| Total | $566,530 |
McNulty received $289.3K in salary, accounting for 51% of the total pay in 2016.
McNulty also received $54K in non-equity incentive plan, $207.9K in option awards and $15.3K in other compensation.
Rankings
In 2016, Christopher McNulty's compensation ranked 10,730th out of 14,075 executives tracked by ExecPay. In other words, McNulty earned more than 23.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,730 out of 14,075 | 24th |
Division Manufacturing | 4,167 out of 5,489 | 24th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 556 out of 827 | 33rd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 329 out of 510 | 36th |
Industry Surgical and Medical Instruments and Apparatus | 198 out of 313 | 37th |
Source: SEC filing on April 27, 2018.
McNulty's colleagues
We found six more compensation records of executives who worked with Christopher McNulty at InVivo Therapeutics Holdings in 2016.
2016
Pamela Stahl
InVivo Therapeutics Holdings
Chief Commercial Officer
2016
Mark Perrin
InVivo Therapeutics Holdings
Chief Executive Officer
2016
Thomas Ulich
InVivo Therapeutics Holdings
Chief Scientific Officer
2016
Lorianne Masuoka
InVivo Therapeutics Holdings
Chief Medical Officer
2016
Steven McAllister
InVivo Therapeutics Holdings
Chief Financial Officer
2016
Tamara Joseph
InVivo Therapeutics Holdings